Abstract:Radiation-induced skull base necrosis (RISBN) is a severe and life-threatening late complication following radiotherapy for nasopharyngeal carcinoma (NPC). With the widespread application of intensity-modulated radiation therapy (IMRT) and the prolongation of patient survival, its clinical significance has become increasingly prominent. Based on the latest clinical research evidence and relevant treatment guidelines, this article systematically reviews the epidemiological characteristics, pathophysiological mechanisms, and diagnostic and therapeutic progress of RISBN. The core contents highlight that quantitative staging and classification systems based on anatomy and imaging (such as the RIEVN staging system), which provides a critical basis for individualized treatment decisions; the comprehensive surgical strategy centered on endoscopic radical debridement combined with pedicled vascularized tissue flap reconstruction, which can effectively improve symptoms and survival rate; the risk assessment and protection of the internal carotid artery serve as the pivotal link in determining prognosis; and the multidisciplinary team collaborative model constitutes the cornerstone of optimizing patient management. This article aims to provide clinical references for the standardized and precision-based diagnosis and treatment of this complex complication.